drug
cangrelor
Marketedupdated 3mo agoby Chiesi USA Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying cangrelor
Patent cliff
source: FDA Orange Bookfirst barrier falls
May 13, 2029
~2.7 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (7)
- Jul 10, 2035method-of-use (U-2260)US 10039780
- Jul 10, 2035formulationUS 9295687
- Jul 10, 2035formulationUS 9439921
- Jul 10, 2035formulationUS 9700575
- Mar 9, 2033method-of-use (U-2979)US 8680052
- Nov 10, 2030method-of-use (U-1926)US 94274484.2y
- May 13, 2029method-of-use (U-2260)US 99252652.7y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 20m ago
Found something off?
comments(0)
5-min edit window · permanent after that